Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Fleming Suzanne — Epizyme, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Fleming Suzanne

Fleming Suzanne

SVP at Epizyme, Inc. · on record since Sep 21, 2017

Insider trading activity of Fleming Suzanne

Transactions on record: 2; since Sep 21, 2017

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 13, 2018

Figures computed from official regulatory filings — methodology.

Companies where Fleming Suzanne has traded

Epizyme, Inc.2 tx · Feb 13, 2018

Track record of Fleming Suzanne

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Fleming Suzanne

Co-insiders of Fleming Suzanne

Agarwal ShefaliEpizyme, Inc.
Allen Andrew REpizyme, Inc.
AMGEN INCEpizyme, Inc.
Amgen Ventures LLCEpizyme, Inc.
Astellas Venture Fund I L.P.Epizyme, Inc.
Astellas Venture Management LLCEpizyme, Inc.
BARRETT M JAMESEpizyme, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BARRIS PETER JEpizyme, Inc.

BASKETT FORESTEpizyme, Inc.

BATE KENNETHEpizyme, Inc.

Bay City Capital Fund V Co-Investment Fund LPEpizyme, Inc.

Bay City Capital Fund V, L.P.Epizyme, Inc.

BAY CITY CAPITAL LLCEpizyme, Inc.

Bay City Capital Management V LLCEpizyme, Inc.

Bazemore Robert BEpizyme, Inc.

Beaulieu JosephEpizyme, Inc.

BEVERIDGE, ROY AEpizyme, Inc.

Bogle Grant C.Epizyme, Inc.

CELGENE CORP /DE/Epizyme, Inc.

Celgene European Investment Co LLCEpizyme, Inc.

Conroy Kevin TEpizyme, Inc.

Copeland Robert AEpizyme, Inc.

Daniel Thomas OEpizyme, Inc.

DRANT RYAN DEpizyme, Inc.

EVNIN LUKEEpizyme, Inc.

Foley ToddEpizyme, Inc.

GADICKE ANSBERTEpizyme, Inc.

Garbacz StephenEpizyme, Inc.

Giordano Michael FEpizyme, Inc.

GOLDFISCHER CARLEpizyme, Inc.

Gould Robert JEpizyme, Inc.

Graf Susan EEpizyme, Inc.

Hedrick EricEpizyme, Inc.

Ho Peter Tai-ChingEpizyme, Inc.

Horvitz H RobertEpizyme, Inc.

KAILIAN VAUGHN MEpizyme, Inc.

KERINS PATRICK JEpizyme, Inc.

KLEINER PERKINS CAUFIELD & BYERS XIII, LLCEpizyme, Inc.

KOLLURI KRISHNA KITTUEpizyme, Inc.

Korn JeraldEpizyme, Inc.

KPCB XIII Associates, LLCEpizyme, Inc.

Kutok JefferyEpizyme, Inc.

Legorreta Pablo G.Epizyme, Inc.

MOTT DAVID MEpizyme, Inc.

MPM Asset Management Investors BV4 LLCEpizyme, Inc.

MPM BioVentures IV GmbH & Co. Beteiligungs KGEpizyme, Inc.

MPM BioVentures IV GP LLCEpizyme, Inc.

MPM BioVentures IV LLCEpizyme, Inc.

MPM BioVentures IV QP LPEpizyme, Inc.

MPM BioVentures IV Strategic Fund, L.P.Epizyme, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Epizyme, Inc.	Feb 13, 2018	AwardD	29,002	0.00 USD	$0	SEC
Epizyme, Inc.	Sep 21, 2017	AwardD	90,180	0.00 USD	$0	SEC